Medicare Enrolled

Dr. Daniel Tan, M.D.

Psychiatry · Houston, TX
10101 SOUTHWEST FWY, Houston, TX 77074
7137794200
Registered in NPPES since 2007
NPI: 1811193766 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tan

Dr. Daniel Tan is a psychiatry specialist in Houston, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Tan received a total of $290,835 from 34 pharmaceutical and/or device companies across 1501 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tan is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $290,835 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$290,835
Total received (2018-2024)
Avg $41,548/year across 7 years
Top 1% in TX for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
1,501
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$34,640
2023
$33,054
2022
$23,793
2021
$22,218
2020
$32,913
2019
$64,406
2018
$79,812

Payments by company (2024)

Supernus Pharmaceuticals, Inc.
$21,216
Noven Pharmaceuticals, Inc.
$8,913
Teva Pharmaceuticals USA, Inc.
$750
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$541
Corium, LLC
$455
Lundbeck LLC
$438
Otsuka America Pharmaceutical, Inc.
$405
Janssen Pharmaceuticals, Inc
$388
Vanda Pharmaceuticals Inc.
$304
Tris Pharma Inc
$241
Axsome Therapeutics, Inc.
$229
E.R. Squibb & Sons, L.L.C.
$173
Noven Therapeutics, LLC
$144
Neurocrine Biosciences, Inc.
$134
BioXcel Therapeutics, Inc.
$124
Indivior Inc.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$46
Alkermes, Inc.
$39
ABBVIE INC.
$37
Top 3 companies account for 89.1% of 2024 payments
All-time payments by company (2018-2024) ›
Tris Pharma Inc
$92,275
Ironshore Pharmaceuticals Inc.
$80,659
Supernus Pharmaceuticals, Inc.
$54,036
Sunovion Pharmaceuticals Inc.
$19,433
Noven Pharmaceuticals, Inc.
$8,937
Neos Therapeutics, LP
$8,427
Corium, LLC
$5,923
Teva Pharmaceuticals USA, Inc.
$2,753
Otsuka America Pharmaceutical, Inc.
$2,643
Validus Pharmaceuticals LLC
$2,339
ITI, Inc.
$1,657
IRONSHORE PHARMACEUTICALS INC.
$1,640
Janssen Pharmaceuticals, Inc
$1,445
Alkermes, Inc.
$1,354
Takeda Pharmaceuticals U.S.A., Inc.
$1,288
Rhodes Pharmaceuticals L.P.
$999
Lundbeck LLC
$841
Shire North American Group Inc
$570
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$541
Noven Therapeutics, LLC
$492
AbbVie Inc.
$424
Vanda Pharmaceuticals Inc.
$304
ABBVIE INC.
$277
Axsome Therapeutics, Inc.
$274
Indivior Inc.
$264
Neurocrine Biosciences, Inc.
$241
E.R. Squibb & Sons, L.L.C.
$173
Vertical Pharmaceuticals, LLC
$125
Neurocrine BioSciences, Inc.
$124
BioXcel Therapeutics, Inc.
$124
Corium, Inc.
$113
Adlon Therapeutics L.P.
$105
Bausch Health US, LLC
$18
Neuronetics, Inc.
$17
Top 3 companies account for 78.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Austedo XR · Auvelity · Azstarys · CAPLYTA · COBENFY · Dyanavel XR · Equetro · FANAPT · HETLIOZ · IGALMI · INGREZZA · INVEGA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LYBALVI · METHYLPHENIDATE 72 · NEUROSTAR TMS THERAPY · OSMOLEX ER · Onyda XR · PERSERIS · QELBREE · Qelbree · Quillichew ER · Quillivant · Quillivant XR · RELEXXII · REXULTI · SECUADO · SPRAVATO · Secuado · TRINTELLIX · Trintellix · UZEDY · VRAYLAR · VYVANSE · Xelstrym · Zolpimist
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in Houston?
Compare psychiatrists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
759
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
WEST OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tan is a psychiatry specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Tan receive payments from pharmaceutical companies?
Yes. Dr. Tan received a total of $290,835 from 34 companies across 1,501 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Tan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →